These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7222348)

  • 1. [Thrombocyte aggregation in vascular diseases of the eye].
    Tartakovskaia AI; Sosipatrova GV
    Vestn Oftalmol; 1981; (1):30-2. PubMed ID: 7222348
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current aspects of drug correction of impaired circulation in the ocular vessels].
    Kiseleva TN; Polunin GS; Lagutina IuM
    Vestn Oftalmol; 2007; 123(2):37-9. PubMed ID: 17650609
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thrombocyte Aggregometer 78--an apparatus for turbidimetric measurement of the spontaneous platelet aggregation time].
    Norden C; Zeschke G; Kühne L; Heinemann L; Stepanauskas M; Heine H
    Z Med Lab Diagn; 1980; 21(3):151-4. PubMed ID: 7434860
    [No Abstract]   [Full Text] [Related]  

  • 4. [Symptomatologic value of the oscillatory potential and its relations to the other ERG waves].
    Jayle GE; Tassy A; Ah Hot L
    Ann Ocul (Paris); 1971 Sep; 204(9):955-68. PubMed ID: 5113900
    [No Abstract]   [Full Text] [Related]  

  • 5. [Disorders of thrombocyte function--diagnosis and therapy].
    Voss R
    Krankenpfl J; 1996 Sep; 34(9):374-80. PubMed ID: 8948996
    [No Abstract]   [Full Text] [Related]  

  • 6. The in vitro effects of a novel vascular protectant, AGI-1067, on platelet aggregation and major receptor expression in subjects with multiple risk factors for vascular disease.
    Serebruany V; Malinin A; Scott R
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):191-6. PubMed ID: 17056832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consistent platelet inhibition during long-term maintenance-dose clopidogrel therapy among 359 compliant outpatients with documented vascular disease.
    Serebruany VL; Malinin AI; Atar D; Hanley DF
    Am Heart J; 2007 Mar; 153(3):371-7. PubMed ID: 17307414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of activated autoplasma on platelet aggregation in patients with vascular diseases of the fundus oculi].
    Mukha AI; Lysenko VS; Galileeva VV; Bunin AIa
    Vestn Oftalmol; 1998; 114(3):32-4. PubMed ID: 9720397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Limits of platelet aggregation tests for investigating thromboses (author's transl)].
    Sie P; Cousin F; Barret A; Caranobe C; Boneu B; Bierme R
    Nouv Presse Med; 1980 Oct; 9(36):2629-32. PubMed ID: 7433051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of the antirheumatic drug Sulindac on thrombocyte function (author's transl)].
    Schenk H; Klein G; Neubauer M; Pilger E
    Wien Med Wochenschr; 1980 May; 130(10):344-9. PubMed ID: 7434788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease.
    Kunicki TJ; Williams SA; Nugent DJ; Harrison P; Segal HC; Syed A; Rothwell PM
    Thromb Haemost; 2009 Jan; 101(1):123-33. PubMed ID: 19132198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet function testing in atherothrombotic disease: steps forward in managing resistance to antiplatelet therapy.
    Grove EL; Hvas AM; Kristensen SD
    Kardiol Pol; 2008 Apr; 66(4):478-9. PubMed ID: 19496276
    [No Abstract]   [Full Text] [Related]  

  • 13. Iron-induced platelet aggregation measurement: a novel method to measure platelet function in stenting for ST segment elevation myocardial infarction.
    Smit JJ; van Oeveren W; Ottervanger JP; Slingerland RJ; Remijn JA; Zijlstra F; van 't Hof AW
    Eur J Clin Invest; 2009 Feb; 39(2):103-9. PubMed ID: 19200163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet function testing in cardiovascular diseases.
    Michelson AD
    Circulation; 2004 Nov; 110(19):e489-93. PubMed ID: 15533872
    [No Abstract]   [Full Text] [Related]  

  • 15. [ADP-induced platelet aggregation in vascular diseases of the elderly].
    Pernigotti L; Molaschi M; Macchione C; Ferrario E; Poli L
    Minerva Med; 1981 Oct; 72(39):2617-20. PubMed ID: 7290465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The condition of vascular-thrombocyte hemostasis in the elderly with arterial hypertension].
    Nosov VP; Borovkov NN; Bashiukova OG
    Klin Med (Mosk); 2005; 83(12):32-6. PubMed ID: 16502721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100).
    Dyszkiewicz-Korpanty A; Olteanu H; Frenkel EP; Sarode R
    Platelets; 2007 Nov; 18(7):491-6. PubMed ID: 17852774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a rationale of platelet aggregation monitoring in stroke prophylaxis?
    von Lewinski F; Riggert J; Paulus W
    J Stroke Cerebrovasc Dis; 2009; 18(2):111-5. PubMed ID: 19251186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point-of-care devices for monitoring anti-platelet therapy.
    van Werkum JW; Heestermans AA; ten Berg JM
    Thromb Res; 2006; 118(6):769-70. PubMed ID: 16504252
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
    Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
    Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.